secwatch.observer — SEC 8-K summary
======================================

Issuer:     Verrica Pharmaceuticals Inc. (VRCA)
CIK:        0001660334
Form:       8-K
Filed at:   2024-06-10T23:59:59+00:00
Accession:  0001193125-24-158353
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Shareholders elect directors and approve advisory proposals at 2024 annual meeting
--------------------------------------------------------------------------------

- Elected Ted White (13,091,028 for) and Mark Prygocki (12,503,147 for) as directors.
- Advisory vote on executive compensation approved: 12,760,245 for, 1,932,076 against.
- Advisory vote on frequency of say-on-pay: one year selected with 14,797,140 votes.
- Ratification of KPMG LLP as independent auditor approved: 37,151,871 for, 678,830 against.
- Approximately 89.2% of outstanding shares were present or represented at the meeting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1660334/000119312524158353/0001193125-24-158353-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1660334/000119312524158353/d834681d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-158353

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer